These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14732950)

  • 1. Pharmacokinetic properties and their relation to certain physicochemical properties.
    Seydel JK
    Eur J Toxicol Hyg Environ; 1972; 5(5 Suppl):39-52. PubMed ID: 14732950
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships and drug disposition.
    Lien EJ
    Annu Rev Pharmacol Toxicol; 1981; 21():31-61. PubMed ID: 7016008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties.
    Mälkiä A; Murtomäki L; Urtti A; Kontturi K
    Eur J Pharm Sci; 2004 Sep; 23(1):13-47. PubMed ID: 15324921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective.
    Afouna MI; Fincher TK; Khan MA; Reddy IK
    Chirality; 2003 May; 15(5):456-65. PubMed ID: 12692892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physicochemical involvement in pharmacokinetic processes].
    Botrè C; Guidotti M
    Boll Chim Farm; 1978 Apr; 117(4):189-216. PubMed ID: 743369
    [No Abstract]   [Full Text] [Related]  

  • 9. The Øie-Tozer model of drug distribution and its suitability for drugs with different pharmacokinetic behavior.
    Stepensky D
    Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1233-43. PubMed ID: 21919805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physicochemical mechanisms of the organotropism of drugs].
    Sergeev PV; Shimanovskiĭ NL
    Vestn Akad Med Nauk SSSR; 1984; (11):85-8. PubMed ID: 6397000
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics.
    Smith DA; Jones BC; Walker DK
    Med Res Rev; 1996 May; 16(3):243-66. PubMed ID: 8727426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parabolic structure-activity relationships: a simple pharmacokinetic model.
    Aarons L; Bell D; Waigh R; Ye Q
    J Pharm Pharmacol; 1982 Nov; 34(11):746-9. PubMed ID: 6129312
    [No Abstract]   [Full Text] [Related]  

  • 13. Revisiting the rule of five on the basis of pharmacokinetic data from rat.
    Ridder L; Wang H; de Vlieg J; Wagener M
    ChemMedChem; 2011 Nov; 6(11):1967-70. PubMed ID: 21932224
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular and pharmacokinetic properties of 222 commercially available oral drugs in humans.
    Sakaeda T; Okamura N; Nagata S; Yagami T; Horinouchi M; Okumura K; Yamashita F; Hashida M
    Biol Pharm Bull; 2001 Aug; 24(8):935-40. PubMed ID: 11510489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters.
    Buchwald P; Bodor N
    Pharmazie; 2002 Feb; 57(2):87-93. PubMed ID: 11878195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Structure-Pharmacokinetic Relationships for drug distribution properties by using general regression neural network.
    Yap CW; Chen YZ
    J Pharm Sci; 2005 Jan; 94(1):153-68. PubMed ID: 15761939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of apparent volume of distribution in obesity.
    Ritschel WA; Kaul S
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):239-47. PubMed ID: 3724300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative variables in drug discovery: promises and challenges.
    Abad-Zapatero C; Champness EJ; Segall MD
    Future Med Chem; 2014 Apr; 6(5):577-93. PubMed ID: 24649959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.